MedWatch

Novo Nordisk waves goodbye to VP in charge of device development

Kenneth Strømdahl has left Novo Nordisk after 17 year with the company. The past few years, he was responsible for the pharmaceutical company's Devices and Delivery Solutions division, where he oversaw more than 300 employees and the development of devices helping patients handle their diseases.

Photo: Novo Nordisk / PR

After 17 years in several positions at Novo Nordisk, Kenneth Strømdahl is off to pastures new.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs